Pulmonary function testing in patients with liver cirrhosis (Review)

Liver cirrhosis is a common long‑term outcome of chronic hepatic inflammation. Patients with liver may also have pulmonary complications. There are several reasons for dysfunction in cirrhosis, including intrinsic cardiopulmonary unrelated to disease and specific disorders related the presence and/or portal hypertension. The most prevalent clinically significant complications hydrothorax, hepatopulmonary syndrome, spontaneous empyema portopulmonary Pulmonary function tests (PFTs) traditionally been used assess lung patients cirrhosis. To best our knowledge, present review first detail all types PFTs performed discuss their clinical significance. reduced values spirometric parameters, diffusion capacity carbon monoxide (DLCO), volumes, maximal inspiratory pressure expiratory pressure. Furthermore, they higher closing volume, greater airway occlusion 0.1 sec after onset flow exhaled nitric oxide values. In order improve function, ascites require therapeutic paracentesis. Such findings should be considered when evaluating individuals disease, particularly those who surgery. Poor restrictive can an impact on post‑transplant outcomes, such as ventilator time, length hospital duration post‑operative complications; thus, transplant care team needs aware its prevalence relevance.